| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/21/2005 | US20050158309 Gonadotropin-releasing hormone (gnrh); gene expression inhibition; for treatment of T-cell related neoplastic diseases |
| 07/21/2005 | US20050158305 Monoclonal antibody for treatment of cancer, autoimmune diseases and rheumatoid arthritis; complementarity determining regions |
| 07/21/2005 | US20050158302 Methods for diagnosing and treating autoimmune disease |
| 07/21/2005 | US20050158301 Arg-Gly-Asp-Ala-Xaa-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val, or a C-terminal truncated fragment of the polypeptide having six or more amino acids. Xaa is alanine, glycine, serine, or an S-protected cysteine; wound healing agent, cardiac repair, bone, promote cartilage repair or growth; antirestenosis |
| 07/21/2005 | US20050158300 Compositions and methods for modulating muscle cell and tissue contractility |
| 07/21/2005 | US20050158299 Administering aspartic acid peptidases, thiol peptidases, metallopeptidases, serine peptidases, threonine peptidases, alkaline peptidases, semi-alkaline peptidases, neutral proteases or mixtures for treating pain of chronic or acute pancreatitis or related conditions |
| 07/21/2005 | US20050158298 Leucine aminopeptidase polypeptide, carboxypeptidases polypeptide; dermatophyte; degradation of polypeptide substrate; Exonuclease X of Escherichia coli ( EXOX protein); fungicides; |
| 07/21/2005 | US20050158297 treating deficiency in mannan binding lectin-associated serine protease-2 (MASP-2) by administering intravenously an amino acid sequence that is a serine protease that acts in the mannan binding Lectin complement fixation pathway |
| 07/21/2005 | US20050158296 administering to a patient suffering from a lysosomal storage disease a P97 conjugated with an enzyme which is capable of transportation into the lysosomes of cells on either sides of the blood brain barrier |
| 07/21/2005 | US20050158295 Modified plasminogen inhibitor type-1 and methods based thereon |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | US20050158287 Methods for using the obese gene and its gene product to identify hematopoietic progenitor cells |
| 07/21/2005 | US20050158282 epidermal growth factor (EGF) producing Lactococcus lactis and Lactobacillus casei ( lactic acid bacterium); useful to treat Short Bowel Syndrome; increase intestinal villi height |
| 07/21/2005 | US20050158276 Bordetella pertussis antigen consisting lipopolysaccharide, pertusis toxin, filamentous hemagglutinin, pertactin or abosrbed to alum; interleukin-12 ; enhances cell-mediated immunity in a host |
| 07/21/2005 | US20050158275 Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture |
| 07/21/2005 | US20050158274 Therapeutic use of a fibrosing agent to induces a fibrotic response at a specific site, thereby providing the patient with pulmonary sealing |
| 07/21/2005 | US20050158253 Enzyme and an enzyme-anchor complex; degrades biofilm structures; complex acts as a bactericide |
| 07/21/2005 | US20050158252 Method and compositions for oral hygiene |
| 07/21/2005 | US20050158250 Granulated composition of soluble, powdered insulin and a carrier of aggregated crystalline cellulose; increases a blood insulin concentration |
| 07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
| 07/21/2005 | DE10361444A1 Verfahren zur in vitro Differenzierung neuronaler Stammzellen oder von neuronalen Stammzellen abgeleiteter Zellen A method for in vitro differentiation of neural stem cells derived from neural stem cells or cells |
| 07/21/2005 | DE10359798A1 Cyclohexadepsipeptide zur Bekämpfung von Endoparasiten und ein Verfahren zu ihrer Herstellung Cyclohexadepsipeptides for controlling endoparasites and a method for their preparation |
| 07/21/2005 | DE10359351A1 DNA-Sequenz und rekombinante Herstellung von Gruppe-4 Majorallergenen aus Getreiden DNA sequence and recombinant production of group 4 major allergens from cereals |
| 07/21/2005 | DE10024383B4 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells |
| 07/21/2005 | CA2592891A1 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 07/21/2005 | CA2592631A1 Compositions and methods to treat recurrent medical conditions |
| 07/21/2005 | CA2553211A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer |
| 07/21/2005 | CA2552526A1 Glucagon-like peptide-1 analogs with long duration of action |
| 07/21/2005 | CA2552222A1 Antiviral compositions which inhibit paramyxovirus infection |
| 07/21/2005 | CA2551877A1 Neutralizing epitope-based growth enhancing vaccine |
| 07/21/2005 | CA2551530A1 Intranasal administration of glucose-regulating peptides |
| 07/21/2005 | CA2551525A1 Pharmaceutical composition for thrombin peptide derivatives |
| 07/21/2005 | CA2551064A1 Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation |
| 07/21/2005 | CA2550854A1 Membranes incorporating recognition moieties |
| 07/21/2005 | CA2550515A1 Protease inhibitors |
| 07/21/2005 | CA2550312A1 Retinal toxicity screening methods |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/21/2005 | CA2548896A1 Multimeric galectin-1 and its use for inducing il-10 production |
| 07/21/2005 | CA2548179A1 Methods and compositions for the production of monoclonal antibodies |
| 07/20/2005 | EP1555318A2 Hematopoietic cytokine receptor |
| 07/20/2005 | EP1555271A1 Peptides useful for diagnosis and therapy of TRP-2+ and/or TRP-1+ tumors |
| 07/20/2005 | EP1555031A1 Angiogenesis inducer |
| 07/20/2005 | EP1555030A1 Sustained release preparation for treating coronary stenosis or obstruction |
| 07/20/2005 | EP1555029A1 Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension |
| 07/20/2005 | EP1554405A1 Compositions, methods, and kits relating to behab and primary cns tumors |
| 07/20/2005 | EP1554403A1 Autism gene |
| 07/20/2005 | EP1554393A2 P27 prevents cellular migration |
| 07/20/2005 | EP1554382A1 Gpr54 knock-out mammals and screening methods using them |
| 07/20/2005 | EP1554310A1 Epididymis-specific gene as potential contraceptive target |
| 07/20/2005 | EP1554308A2 Glucagon-like peptide - 2 variants |
| 07/20/2005 | EP1554306A2 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 07/20/2005 | EP1554305A1 Prion protein-binding peptide sequences |
| 07/20/2005 | EP1554301A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 07/20/2005 | EP1554250A1 Novel lactams and uses thereof |
| 07/20/2005 | EP1554237A1 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs |
| 07/20/2005 | EP1553982A2 METHODS AND COMPOSITIONS FOR MODULATING T HELPER (T sb H /sb ) CELL DEVELOPMENT AND FUNCTION |
| 07/20/2005 | EP1553981A1 Bacterial transforming agent |
| 07/20/2005 | EP1553974A1 Pharmaceutical composition comprising carriers for products |
| 07/20/2005 | EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 07/20/2005 | EP1553972A1 Method of treating chronic pelvic pain syndrome by administration of chrorionic gonadotropin |
| 07/20/2005 | EP1553971A2 THERAPIES FOR RENAL FAILURE USING INTERFERON-b |
| 07/20/2005 | EP1553970A1 Treatment of allergic conditions by use of il 21 |
| 07/20/2005 | EP1553969A1 Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 07/20/2005 | EP1553968A1 Method for treating patients with massive blood loss |
| 07/20/2005 | EP1553967A1 Use of amide derivative of ge 2270 factor a3 for the treatment of acne |
| 07/20/2005 | EP1553966A2 Human papillomavirus polypeptides and immunogenic compositions |
| 07/20/2005 | EP1553965A2 Method of treating tumors |
| 07/20/2005 | EP1553964A2 Ketoamide inhibitors in chronic nerve disease |
| 07/20/2005 | EP1553963A1 Novel agents that modulate eph receptor activity |
| 07/20/2005 | EP1553962A1 Combination chemotherapy with chlorotoxin |
| 07/20/2005 | EP1553960A1 Neuregulin based methods and compositions for treating cardiovascular diseases |
| 07/20/2005 | EP1553959A1 Method for extracting a natural mixture of conjugated equine estrogens that is depleted of non-conjugated lipophilic compounds |
| 07/20/2005 | EP1553955A2 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 07/20/2005 | EP1553935A2 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 07/20/2005 | EP1553913A1 Compositions and methods for softening, thinning and removing hyperkeratotic tissue |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1553827A2 Medical device and method for tissue removal and repair |
| 07/20/2005 | EP1553824A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 07/20/2005 | EP1401467A4 Alpha-fetoprotein peptides and uses thereof |
| 07/20/2005 | EP1345605B1 THERMOFORMed SOLID PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF PERINDOPRIL |
| 07/20/2005 | EP1317309B1 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
| 07/20/2005 | EP1299348A4 Compounds and compositions for delivering active agents |
| 07/20/2005 | EP1280521B1 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates |
| 07/20/2005 | EP1263774B1 Gamma-secretase inhibitors |
| 07/20/2005 | EP1241254B1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 07/20/2005 | EP1229965B1 Placental human neurokinin b precursor |
| 07/20/2005 | EP1226164A4 Human metabotropic glutamate receptor |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP1180243B1 Uses of notch related genes |
| 07/20/2005 | EP1169052B1 Vegf angiogenic growth factors for treatment of peripheral neuropathy |
| 07/20/2005 | EP1152757B1 Mmp inhibitors in connective tissue softening |
| 07/20/2005 | EP1131113B1 Bioactive prostheses of a conductive material coated with a polymer and a substance with immunosuppressive, antistenotic and antithrombotic properties |
| 07/20/2005 | EP1121137B1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 07/20/2005 | EP1011648B2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 07/20/2005 | EP1005538B1 Potassium channel proteins for use in gene therapy for alleviating erectile dysfunction |
| 07/20/2005 | EP0979281B1 A method for making multispecific antibodies having heteromultimeric and common components |
| 07/20/2005 | EP0977586B1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 07/20/2005 | EP0965637B1 Fas ANTIGEN DERIVATIVES |
| 07/20/2005 | EP0946593B1 Use of hcc-1 for treating thrombocytopenia |